Our findings suggest that if Mgmt methylation status is more of a dynamic process, regulated by the circadian clock, than a fixed and unchanging characteristic of the tumor, then therapeutically targeting the circadian clock may be an effective approach to boost daily rhythms in Mgmt methylation and increase its silencing at key times of the day. Here, CLOCK is linked to neoplasm.